Literature DB >> 15934132

Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in opposition.

Maarten Boers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15934132     DOI： 10.1002/art.21106

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  4 in total

Review 1.  [Measuring disease activity for rheumatoid arthritis].

Authors:  D Aletaha; T Stamm; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

2.  New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval.

Authors:  Vittorio Bertele'; Alessandro Assisi; Valeria Di Muzio; Danila Renzo; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2007-07-24       Impact factor: 2.953

3.  Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol.

Authors:  B D Lacroix; M O Karlsson; L E Friberg
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-10-29

4.  Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.

Authors:  Vibeke Strand; Mark Kosinski; Ari Gnanasakthy; Usha Mallya; Shephard Mpofu
Journal:  Health Qual Life Outcomes       Date:  2014-03-05       Impact factor: 3.186
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.